The Yorkshire Cancer Research Centre for Early Phase Clinical Trials.

A new clinical trials network across Yorkshire will test experimental cancer treatments in people for the first time, aiming to move promising therapies from the lab into patients more quickly. This matters because many potential cancer treatments stall between laboratory discovery and routine use. Early-phase trials—proof-of-concept and feasibility studies—are the critical bridge, but they require specialised infrastructure, experienced teams, and coordinated patient recruitment that individual hospitals often cannot provide alone. Yorkshire currently lacks a unified network to run these studies efficiently, meaning local patients may miss opportunities to access novel therapies, and promising scientific leads from the region’s researchers may not be tested promptly. If successful, the network will accelerate the flow of new treatments into clinical practice, particularly in radiotherapy/drug combinations, biological therapies, and novel therapeutic targets. It will also train early-career clinicians to become the next generation of clinical research leaders, building long-term capacity. The impact is primarily infrastructural: a more efficient system for running early-phase trials, rather than a single new drug or device. Patients in Yorkshire could gain earlier access to experimental treatments, and the region’s research community will be better equipped to turn scientific questions into real-world answers.